Esposito M - Search Results

1

Etanercept, childhood and long-term safety: a case of five years treatment.

Mazzotta A, Saraceno R, Esposito M, Chimenti S. Mazzotta A, et al. Among authors: esposito m. Eur J Dermatol. 2011 Sep-Oct;21(5):776-7. doi: 10.1684/ejd.2011.1432. Eur J Dermatol. 2011. PMID: 21697062 No abstract available.

2

Treatment of erythrodermic psoriasis with etanercept.

Esposito M, Mazzotta A, de Felice C, Papoutsaki M, Chimenti S. Esposito M, et al. Br J Dermatol. 2006 Jul;155(1):156-9. doi: 10.1111/j.1365-2133.2006.07217.x. Br J Dermatol. 2006. PMID: 16792768 Clinical Trial.

3

Etanercept at different dosages in the treatment of generalized pustular psoriasis: a case series.

Esposito M, Mazzotta A, Casciello C, Chimenti S. Esposito M, et al. Dermatology. 2008;216(4):355-60. doi: 10.1159/000117706. Epub 2008 Feb 20. Dermatology. 2008. PMID: 18285687

4

Long-term efficacy of etanercept in hidradenitis suppurativa.

Zangrilli A, Esposito M, Mio G, Mazzotta A, Chimenti S. Zangrilli A, et al. Among authors: esposito m. J Eur Acad Dermatol Venereol. 2008 Nov;22(10):1260-2. doi: 10.1111/j.1468-3083.2008.02617.x. Epub 2008 Mar 7. J Eur Acad Dermatol Venereol. 2008. PMID: 18331322 No abstract available.

5

Continuous treatment of plaque-type psoriasis with etanercept: an observational long-term experience.

Esposito M, Giunta A, Mazzotta A, Babino G, Talamonti M, Chimenti MS, Chimenti S. Esposito M, et al. Int J Immunopathol Pharmacol. 2010 Apr-Jun;23(2):503-9. doi: 10.1177/039463201002300212. Int J Immunopathol Pharmacol. 2010. PMID: 20646345 Free article.

6

High-dose initiation of etanercept in psoriatic arthritis and plaque psoriasis: efficacy, safety and impact on patients' quality of life.

De Felice C, Mazzotta A, Esposito M, Bianchi L, Chimenti S. De Felice C, et al. Among authors: esposito m. J Dermatolog Treat. 2006;17(6):355-8. doi: 10.1080/09546630601028703. J Dermatolog Treat. 2006. PMID: 17853309 Free article. Clinical Trial.

7

Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.

Mazzotta A, Esposito M, Costanzo A, Chimenti S. Mazzotta A, et al. Among authors: esposito m. Am J Clin Dermatol. 2009;10(5):319-24. doi: 10.2165/11310770-000000000-00000. Am J Clin Dermatol. 2009. PMID: 19658444 Clinical Trial.

8

Long-term experience with etanercept in psoriatic arthritis patients: a 3-year observational study.

Mazzotta A, Esposito M, Schipani C, Chimenti S. Mazzotta A, et al. Among authors: esposito m. J Dermatolog Treat. 2009;20(6):354-8. doi: 10.3109/09546630902936752. J Dermatolog Treat. 2009. PMID: 19954392 Free article. Clinical Trial.

9

Efficacy and safety of subcutaneous anti-tumor necrosis factor-alpha agents, etanercept and adalimumab, in elderly patients affected by psoriasis and psoriatic arthritis: an observational long-term study.

Esposito M, Giunta A, Mazzotta A, Zangrilli A, Babino G, Bavetta M, Perricone R, Chimenti S, Chimenti MS. Esposito M, et al. Dermatology. 2012;225(4):312-9. doi: 10.1159/000345623. Epub 2012 Dec 28. Dermatology. 2012. PMID: 23295383

10

Influence and variation of the body mass index in patients treated with etanercept for plaque-type psoriasis.

Esposito M, Mazzotta A, Saraceno R, Schipani C, Chimenti S. Esposito M, et al. Int J Immunopathol Pharmacol. 2009 Jan-Mar;22(1):219-25. doi: 10.1177/039463200902200124. Int J Immunopathol Pharmacol. 2009. PMID: 19309569 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,360 results

Search Page

Filters